FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Infect Immun / Rhodococcus equi secreted antigens are immunogenic and stimu...
Infection and immunity2003; 71(11); 6329-6337; doi: 10.1128/IAI.71.11.6329-6337.2003

Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.

Abstract: Rhodococcus equi is an opportunistic pathogen in immunocompromised humans and an important primary pathogen in young horses. Although R. equi infection can produce life-threatening pyogranulomatous pneumonia, most foals develop a protective immune response that lasts throughout life. The antigen targets of this protective response are currently unknown; however, Mycobacterium tuberculosis is a closely related intracellular pathogen and provides a model system. Based on previous studies of M. tuberculosis protective antigens released into culture filtrate supernatant (CFS), a bacterial growth system was developed for obtaining R. equi CFS antigens. Potential immunogens for prevention of equine rhodococcal pneumonia were identified by using immunoblots. The 48-h CFS contained five virulence-associated protein bands that migrated between 12 and 24 kDa and were recognized by sera from R. equi-infected foals and immune adult horses. Notably, the CFS contained the previously characterized proteins VapC, VapD, and VapE, which are encoded by genes on the R. equi virulence plasmid. R. equi CFS was also examined for the ability to stimulate a type 1-like memory response in immune horses. Three adult horses were challenged with virulent R. equi, and cells from the bronchoalveolar lavage fluid were recovered before and 1 week after challenge. In vitro stimulation of pulmonary T-lymphocytes with R. equi CFS resulted in significant proliferation and a significant increase in gamma interferon mRNA expression 1 week after challenge. These results were consistent with a memory effector response in immune adult horses and provide evidence that R. equi CFS proteins are antigen targets in the immunoprotective response against R. equi infection.
Get Full Text
Publication Date: 2003-10-24 PubMed ID: 14573652PubMed Central: PMC219552DOI: 10.1128/IAI.71.11.6329-6337.2003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study delves into the immune response of horses to Rhodococcus equi, an opportunistic pathogen that primarily affects immunocompromised humans and young horses. The researchers identified potential antigens for preventing equine rhodococcal pneumonia and found that the secreted antigens incite a type 1 memory response in the lungs of immune horses.

Background and Purpose

  • Opportunistic pathogens can cause diseases mainly in those individuals or organisms with weakened immune systems. Rhodococcus equi (R. equi) is one of these pathogens, prevalent in immunocompromised humans and young horses.
  • R. equi infection can lead to severe pneumonia, but most often, foals develop a life-long protective immune response against this pathogen.
  • The key protective antigens, substances that the immune system recognizes as foreign to the body and against which it reacts, remain unknown.
  • The researchers drew insight from the intricate biology of Mycobacterium tuberculosis (a similar pathogen) to develop a method for obtaining potentially protective R. equi antigens.

Methods and Main Findings

  • The researchers cultivated R. equi to produce and release potential antigens in a culture filtrate supernatant (CFS), a bacterial growth system.
  • Five virulence-associated protein bands between 12 and 24 kDa in weight were identified in the CFS that were recognized by sera from foals infected with R. equi and immune adult horses.
  • Among the identified proteins, VapC, VapD, and VapE were identified, all of which are produced by R. equi’s virulence genes.
  • The researchers tested the potential of R. equi CFS to prompt a type 1-like memory response in immune horses by challenging three horses with virulent R. equi and observing changes in their immune response.
  • Results showed a significant proliferation of pulmonary T-lymphocytes (white blood cells) and increased expression of gamma interferon mRNA, which assists in immune response one week after challenge, suggesting a memory effector response.

Implications and Conclusion

  • The findings suggest that R. equi CFS proteins are antigen targets that counterattack R. equi infection, thereby helping the immune system to recognize and rapidly response to the pathogen.
  • These results may pave the path towards the development of effective immunization techniques against Rhodococcus equi, thereby preventing severe pneumonia in horses and possibly offering insights into immune response mechanisms in other animals and humans.

Cite This Article

APA
Kohler AK, Stone DM, Hines MT, Byrne BA, Alperin DC, Norton LK, Hines SA. (2003). Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect Immun, 71(11), 6329-6337. https://doi.org/10.1128/IAI.71.11.6329-6337.2003

Publication

Infection and immunity
ISSN: 0019-9567
NlmUniqueID: 0246127
Country: United States
Language: English
Volume: 71
Issue: 11
Pages: 6329-6337

Researcher Affiliations

Kohler, Andrea K
  • Department of Veterinary Microbiology and Pathology,Washington State University, Pullman, Washington 99164-7040, USA.
Stone, Diana M
    Hines, Melissa T
      Byrne, Barbara A
        Alperin, Debra C
          Norton, Linda K
            Hines, Stephen A

              MeSH Terms

              • Actinomycetales Infections / immunology
              • Actinomycetales Infections / veterinary
              • Animals
              • Antigens, Bacterial / immunology
              • Horse Diseases / immunology
              • Horses
              • Immunologic Memory
              • Interferon-gamma / biosynthesis
              • Lung / immunology
              • Lymphocyte Activation
              • Plasmids
              • Rhodococcus equi / immunology

              References

              This article includes 45 references
              1. Allen G, Yeargan M, Costa LR, Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.. J Virol 1995 Jan;69(1):606-12.
                pmc: PMC188619pubmed: 7983765doi: 10.1128/jvi.69.1.606-612.1995google scholar: lookup
              2. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth.. Infect Immun 1991 Jun;59(6):1905-10.
                pmc: PMC257941pubmed: 1903768doi: 10.1128/iai.59.6.1905-1910.1991google scholar: lookup
              3. Andersen P, Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis.. Infect Immun 1993 Mar;61(3):844-51.
                pmc: PMC302810pubmed: 8432604doi: 10.1128/iai.61.3.844-851.1993google scholar: lookup
              4. Andersen P. The T cell response to secreted antigens of Mycobacterium tuberculosis.. Immunobiology 1994 Oct;191(4-5):537-47.
                pubmed: 7713568doi: 10.1016/s0171-2985(11)80460-2google scholar: lookup
              5. Andersen P, Andersen AB, Sørensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.. J Immunol 1995 Apr 1;154(7):3359-72.
                pubmed: 7897219
              6. Arend SM, Andersen P, van Meijgaarden KE, Skjot RL, Subronto YW, van Dissel JT, Ottenhoff TH. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10.. J Infect Dis 2000 May;181(5):1850-4.
                pubmed: 10823800doi: 10.1086/315448google scholar: lookup
              7. Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes.. J Exp Med 1971 Sep 1;134(3 Pt 1):713-40.
                pmc: PMC2139093pubmed: 15776571doi: 10.1084/jem.134.3.713google scholar: lookup
              8. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.. Nature 1994 Dec 15;372(6507):691-4.
                pubmed: 7527500doi: 10.1038/372691a0google scholar: lookup
              9. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis.. Infect Immun 1995 Apr;63(4):1491-7.
                pmc: PMC173180pubmed: 7890415doi: 10.1128/iai.63.4.1491-1497.1995google scholar: lookup
              10. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis.. Infect Immun 2000 Feb;68(2):791-5.
                pmc: PMC97206pubmed: 10639447doi: 10.1128/iai.68.2.791-795.2000google scholar: lookup
              11. Byrne BA, Prescott JF, Palmer GH, Takai S, Nicholson VM, Alperin DC, Hines SA. Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins.. Infect Immun 2001 Feb;69(2):650-6.
                pmc: PMC97935pubmed: 11159951doi: 10.1128/iai.69.2.650-656.2001google scholar: lookup
              12. Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.. J Immunol 2001 May 15;166(10):6227-35.
                pubmed: 11342645doi: 10.4049/jimmunol.166.10.6227google scholar: lookup
              13. Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case.. Rev Infect Dis 1991 Jan-Feb;13(1):91-6.
                pubmed: 2017640doi: 10.1093/clinids/13.1.91google scholar: lookup
              14. Giguère S, Hondalus MK, Yager JA, Darrah P, Mosser DM, Prescott JF. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.. Infect Immun 1999 Jul;67(7):3548-57.
                pmc: PMC116543pubmed: 10377138doi: 10.1128/iai.67.7.3548-3557.1999google scholar: lookup
              15. Giguère S, Prescott JF. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction.. Vet Immunol Immunopathol 1999 Jan 4;67(1):1-15.
                pubmed: 9950350doi: 10.1016/s0165-2427(98)00212-8google scholar: lookup
              16. Goodfellow M. The taxonomic status of Rhodococcus equi.. Vet Microbiol 1987 Aug;14(3):205-9.
                pubmed: 3672864doi: 10.1016/0378-1135(87)90106-4google scholar: lookup
              17. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals.. Vet Microbiol 1987 Aug;14(3):307-20.
                pubmed: 3672873doi: 10.1016/0378-1135(87)90118-0google scholar: lookup
              18. Hines MT, Paasch KM, Alperin DC, Palmer GH, Westhoff NC, Hines SA. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses.. Vet Immunol Immunopathol 2001 May 10;79(1-2):101-14.
                pubmed: 11356253doi: 10.1016/s0165-2427(01)00258-6google scholar: lookup
              19. Hines SA, Kanaly ST, Byrne BA, Palmer GH. Immunity to Rhodococcus equi.. Vet Microbiol 1997 Jun 16;56(3-4):177-85.
                pubmed: 9226832doi: 10.1016/s0378-1135(97)00086-2google scholar: lookup
              20. Hines SA, Stone DM, Hines MT, Alperin DC, Knowles DP, Norton LK, Hamilton MJ, Davis WC, McGuire TC. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.. Clin Diagn Lab Immunol 2003 Mar;10(2):208-15.
                pmc: PMC150533pubmed: 12626444doi: 10.1128/cdli.10.2.208-215.2003google scholar: lookup
              21. Horwitz MA, Lee BW, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.. Proc Natl Acad Sci U S A 1995 Feb 28;92(5):1530-4.
                pmc: PMC42553pubmed: 7878014doi: 10.1073/pnas.92.5.1530google scholar: lookup
              22. Kanaly ST, Hines SA, Palmer GH. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.. Infect Immun 1995 Aug;63(8):3037-41.
                pmc: PMC173413pubmed: 7622227doi: 10.1128/iai.63.8.3037-3041.1995google scholar: lookup
              23. Kanaly ST, Hines SA, Palmer GH. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.. Infect Immun 1996 Apr;64(4):1126-32.
                pmc: PMC173893pubmed: 8606068doi: 10.1128/iai.64.4.1126-1132.1996google scholar: lookup
              24. Kaufmann SH, Hess J. Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development.. Immunol Lett 1999 Jan;65(1-2):81-4.
                pubmed: 10065631doi: 10.1016/s0165-2478(98)00128-xgoogle scholar: lookup
              25. Kedlaya I, Ing MB, Wong SS. Rhodococcus equi infections in immunocompetent hosts: case report and review.. Clin Infect Dis 2001 Feb 1;32(3):E39-46.
                pubmed: 11170969doi: 10.1086/318520google scholar: lookup
              26. Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.. Clin Diagn Lab Immunol 2002 Nov;9(6):1270-6.
                pmc: PMC130094pubmed: 12414760doi: 10.1128/cdli.9.6.1270-1276.2002google scholar: lookup
              27. Lozes E, Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Vandenbussche P, Van Vooren JP, Drowart A, Ulmer JB, Liu MA. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.. Vaccine 1997 Jun;15(8):830-3.
                pubmed: 9234526doi: 10.1016/s0264-410x(96)00274-5google scholar: lookup
              28. Madi NM, Al-Attiya R, Shaban FA, Mustafa AS, Abal AT, Ofung F, Wiker HG, Ravn P, Andersen P. Effective chemotherapy restores T-cell responses to M. tuberculosis antigens in tuberculosis patients. p. 439-442. In G. P. Talwar, I. Nath, N. K. Ganguly, and K. V. S. Rao (ed.), Proceedings of the 10th International Immunology Congress, 1998. Monduzzi Editore, S.p.A., Bologna, Italy.
              29. Mendez-Samperio P, Gonzalez-Garcia L, Pineda-Fragoso PR, Ramos-Sanchez E. Specificity of T cells in human resistance to Mycobacterium tuberculosis infection.. Cell Immunol 1995 May;162(2):194-201.
                pubmed: 7743546doi: 10.1006/cimm.1995.1069google scholar: lookup
              30. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis.. Infect Immun 1991 Jan;59(1):372-82.
                pmc: PMC257751pubmed: 1898899doi: 10.1128/iai.59.1.372-382.1991google scholar: lookup
              31. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.. Infect Immun 2001 May;69(5):2773-8.
                pmc: PMC98224pubmed: 11292688doi: 10.1128/iai.69.5.2773-2778.2001google scholar: lookup
              32. Sinha RK, Verma I, Khuller GK. Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra.. Vaccine 1997 Apr-May;15(6-7):689-99.
                pubmed: 9178471doi: 10.1016/s0264-410x(96)00230-7google scholar: lookup
              33. Smith SM, Brookes R, Klein MR, Malin AS, Lukey PT, King AS, Ogg GS, Hill AV, Dockrell HM. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.. J Immunol 2000 Dec 15;165(12):7088-95.
                pubmed: 11120838doi: 10.4049/jimmunol.165.12.7088google scholar: lookup
              34. Sonnenberg MG, Belisle JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry.. Infect Immun 1997 Nov;65(11):4515-24.
                pmc: PMC175649pubmed: 9353028doi: 10.1128/iai.65.11.4515-4524.1997google scholar: lookup
              35. Sørensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis.. Infect Immun 1995 May;63(5):1710-7.
                pmc: PMC173214pubmed: 7729876doi: 10.1128/iai.63.5.1710-1717.1995google scholar: lookup
              36. Takai S, Michizoe T, Matsumura K, Nagai M, Sato H, Tsubaki S. Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice.. Microbiol Immunol 1985;29(12):1175-84.
                pubmed: 3831718doi: 10.1111/j.1348-0421.1985.tb00907.xgoogle scholar: lookup
              37. Takai S, Iie M, Watanabe Y, Tsubaki S, Sekizaki T. Virulence-associated 15- to 17-kilodalton antigens in Rhodococcus equi: temperature-dependent expression and location of the antigens.. Infect Immun 1992 Jul;60(7):2995-7.
                pmc: PMC257265pubmed: 1612765doi: 10.1128/iai.60.7.2995-2997.1992google scholar: lookup
              38. Takai S, Iie M, Kobayashi C, Morishita T, Nishio T, Ishida T, Fujimura T, Sasaki Y, Tsubaki S. Monoclonal antibody specific to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi.. J Clin Microbiol 1993 Oct;31(10):2780-2.
                pmc: PMC266013pubmed: 8253982doi: 10.1128/jcm.31.10.2780-2782.1993google scholar: lookup
              39. Takai S. Epidemiology of Rhodococcus equi infections: a review.. Vet Microbiol 1997 Jun 16;56(3-4):167-76.
                pubmed: 9226831doi: 10.1016/s0378-1135(97)00085-0google scholar: lookup
              40. Takai S, Kobayashi C, Murakami K, Sasaki Y, Tsubaki S. Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice.. FEMS Immunol Med Microbiol 1999 May;24(1):1-9.
                pubmed: 10340706doi: 10.1111/j.1574-695x.1999.tb01258.xgoogle scholar: lookup
              41. Tan C, Prescott JF, Patterson MC, Nicholson VM. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity.. Can J Vet Res 1995 Jan;59(1):51-9.
                pmc: PMC1263734pubmed: 7704843
              42. Taouji S, Bréard E, Peyret-Lacombe A, Pronost S, Fortier G, Collobert-Laugier C. Serum and mucosal antibodies of infected foals recognized two distinct epitopes of VapA of Rhodococcus equi.. FEMS Immunol Med Microbiol 2002 Dec 13;34(4):299-306.
                pubmed: 12443830doi: 10.1111/j.1574-695x.2002.tb00637.xgoogle scholar: lookup
              43. Verville TD, Huycke MM, Greenfield RA, Fine DP, Kuhls TL, Slater LN. Rhodococcus equi infections of humans. 12 cases and a review of the literature.. Medicine (Baltimore) 1994 May;73(3):119-32.
                pubmed: 8190035doi: 10.1097/00005792-199405000-00001google scholar: lookup
              44. Weldingh K, Andersen P. Immunological evaluation of novel Mycobacterium tuberculosis culture filtrate proteins.. FEMS Immunol Med Microbiol 1999 Feb;23(2):159-64.
                pubmed: 10076913doi: 10.1111/j.1574-695x.1999.tb01235.xgoogle scholar: lookup
              45. Zink MC, Yager JA, Prescott JF, Fernando MA. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages.. Vet Microbiol 1987 Aug;14(3):295-305.
                pubmed: 3672872doi: 10.1016/0378-1135(87)90117-9google scholar: lookup

              Citations

              This article has been cited 4 times.
              1. Rocha JN, Cohen ND, Bordin AI, Brake CN, Giguère S, Coleman MC, Alaniz RC, Lawhon SD, Mwangi W, Pillai SD. Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.. PLoS One 2016;11(2):e0148111.
                doi: 10.1371/journal.pone.0148111pubmed: 26828865google scholar: lookup
              2. Mealey RH, Stone DM, Hines MT, Alperin DC, Littke MH, Leib SR, Leach SE, Hines SA. Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.. Vaccine 2007 Oct 23;25(43):7582-97.
                doi: 10.1016/j.vaccine.2007.07.055pubmed: 17889970google scholar: lookup
              3. Martens RJ, Cohen ND, Jones SL, Moore TA, Edwards JF. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi.. Infect Immun 2005 Oct;73(10):7040-2.
                doi: 10.1128/IAI.73.10.7040-7042.2005pubmed: 16177388google scholar: lookup
              4. Patton KM, McGuire TC, Fraser DG, Hines SA. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.. Infect Immun 2004 Dec;72(12):7073-83.
                doi: 10.1128/IAI.72.12.7073-7083.2004pubmed: 15557631google scholar: lookup
              Subscribe to our newsletter
              Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.